[Federal Register: August 19, 1999 (Volume 64, Number 160)]
[Notices]               
[Page 45265]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr19au99-79]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

 
Disease, Disability and Injury Prevention and Control Special 
Emphasis Panel: Research Studies to Characterize the Clinical Relevance 
of HIV Superinfection

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting.
    Name: Disease, Disability and Injury Prevention and Control Special 
Emphasis Panel: Research Studies to Characterize the Clinical Relevance 
of HIV Superinfection, Program Announcement #99105.
    Times and Dates: 9 a.m.-9:30 a.m., August 27, 1999 (Open) 9:30 
a.m.-4:30 p.m., August 27, 1999 (Closed).
    Place: Professional and Scientific Associates, 2635 Century 
Parkway, Suite 990, Atlanta, GA. 30345. Telephone 404/633-6477.
    Status: Portions of the meeting will be closed to the public in 
accordance with provisions set forth in section 552b(c)(4) and (6), 
Title 5 U.S.C., and the Determination of the Associate Director for 
Management and Operations, CDC, pursuant to Pub. L. 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
Program Announcement #99105. Due to administrative delays this notice 
is published less than 15 days prior to the meeting.

FOR FURTHER INFORMATION CONTACT: Nancy Pearcey, Prevention Support 
Office, National Center for HIV, STD, and TB Prevention, CDC, Corporate 
Square Office Park, 11 Corporate Square Boulevard, M/S E07, Atlanta, 
Georgia 30329, telephone 404/639-8025, e-mail nxp1@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

    Dated: August 12, 1999.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 99-21503 Filed 8-16-99; 12:19 pm]
BILLING CODE 4163-18-P